Insider Title Company Date Price Return Shares Value
Puhlmann Markus Chief Medical Officer Perspective Therapeutics, Inc. (CATX) 2024-01-24 $5.00 209.0% 28,000 $139,888
Puhlmann Markus Chief Medical Officer Perspective Therapeutics, Inc. (CATX) 2023-12-19 $3.17 387.1% 59,542 $188,737
Return Profit / (loss) Cost
Total 311.3% $1,023,031 $328,625